Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2795 (LINC02795) is a human gene transcribed as a long non-coding RNA (lncRNA) classified specifically as a long intergenic non-coding RNA (lincRNA), meaning it does not overlap protein-coding regions[3][7]. It is longer than 200 nucleotides and does not encode a functional protein. The sequence and genomic locus are annotated (Entrez Gene ID: 105378824)[3], but its specific biological function, molecular mechanisms, or disease associations have not been reported or experimentally validated as of now[1][5]. Like other lincRNAs, it may potentially participate in the regulation of gene expression, chromatin architecture, or transcriptional modulation[7], but no published work establishes a distinct physiological or pathophysiological role for LINC02795 in humans.
Not applicable (no known targeting drugs/mechanisms)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2795 (LINC02795).